$HQY
HEALTHEQUITY, INC. Stock $hqy

$hqy Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-K Financial Statement

#000142833619000006 Filed on March 28, 2019

Income Statement

Concept	2019 Q1	2018 Q1	2017 Q4
Revenue	$75.78M	$60.44M	$56.79M
YoY Change	25.38%	29.1%	30.98%
Cost Of Revenue	$31.33M	$28.79M	$23.06M
YoY Change	8.83%	27.47%	32.03%
Gross Profit	$44.45M	$31.65M	$33.73M
YoY Change	40.44%	30.61%	30.27%
Gross Profit Margin	58.65%	52.36%	59.39%
Selling, General & Admin	$16.40M	$14.20M	$12.14M
YoY Change	15.49%	36.54%	27.07%
% of Gross Profit	36.9%	44.87%	36.01%
Research & Development	$10.00M	$7.500M	$6.866M
YoY Change	33.33%	15.38%	10.58%
% of Gross Profit	22.5%	23.7%	20.36%
Depreciation & Amortization	$4.700M	$4.900M	$700.0K
YoY Change	-4.08%	32.43%	33.84%
% of Gross Profit	10.57%	15.48%	2.08%
Operating Expenses	$27.86M	$23.21M	$20.17M
YoY Change	20.04%	28.61%	19.68%
Operating Profit	$16.58M	$8.434M	$13.56M
YoY Change	96.6%	36.45%	49.99%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$221.0K	-$1.706M	-$395.0K
YoY Change	-87.05%	979.75%	54.3%
Pretax Income	$16.40M	$6.700M	$13.17M
YoY Change	144.78%	11.67%	49.86%
Income Tax	$3.241M	$823.0K	$2.685M
% Of Pretax Income	19.76%	12.28%	20.39%
Net Earnings	$13.12M	$5.905M	$10.48M
YoY Change	122.17%	45.37%	74.47%
Net Earnings / Revenue	17.31%	9.77%	18.46%
Basic Earnings Per Share	$0.21	$0.10	$0.17
Diluted Earnings Per Share	$0.21	$0.09	$0.17
COMMON SHARES
Basic Shares Outstanding	62.47M shares	60.95M shares	60.56M shares
Diluted Shares Outstanding			61.87M shares

Balance Sheet

Concept	2019 Q1	2018 Q1	2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$361.5M	$240.3M	$225.1M
YoY Change	50.44%	33.2%	35.85%
Cash & Equivalents	$361.5M	$199.5M	$184.4M
Short-Term Investments	$0.00	$40.80M	$40.70M
Other Short-Term Assets	$7.534M	$4.676M	$6.100M
YoY Change	61.12%	63.1%	12.96%
Inventory		$215.0K	$169.0K
Prepaid Expenses			$6.106M
Receivables	$25.67M	$21.60M	$21.46M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$394.7M	$265.4M	$252.8M
YoY Change	48.71%	32.16%	35.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.223M	$7.836M	$6.789M
YoY Change	4.94%	51.57%	26.35%
Goodwill	$4.651M	$4.651M	$4.651M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$79.67M	$83.64M	$85.45M
YoY Change	-4.75%	28.63%	30.08%
Long-Term Investments	$209.0K		$206.0K
YoY Change			-26.69%
Other Assets	$21.12M	$18.03M	$1.760M
YoY Change	17.17%	868.67%	-12.13%
Total Long-Term Assets	$115.3M	$103.8M	$103.3M
YoY Change	11.16%	32.49%	31.75%
TOTAL ASSETS
Total Short-Term Assets	$394.7M	$265.4M	$252.8M
Total Long-Term Assets	$115.3M	$103.8M	$103.3M
Total Assets	$510.0M	$369.2M	$356.1M
YoY Change	38.16%	32.25%	34.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.520M	$2.420M	$3.295M
YoY Change	45.45%	-24.87%	108.28%
Accrued Expenses	$8.552M	$5.521M	$9.680M
YoY Change	54.9%	46.84%	130.75%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$29.05M	$20.49M	$19.48M
YoY Change	41.79%	30.48%	86.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.968M	$2.395M	$2.200M
YoY Change	23.92%	59.67%	69.23%
Total Long-Term Liabilities	$3.884M	$2.395M	$2.226M
YoY Change	62.17%	60.42%	54.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$29.05M	$20.49M	$19.48M
Total Long-Term Liabilities	$3.884M	$2.395M	$2.226M
Total Liabilities	$32.94M	$22.89M	$21.70M
YoY Change	43.92%	33.08%	82.69%
SHAREHOLDERS EQUITY
Retained Earnings	$171.9M	$98.31M	$79.35M
YoY Change	74.81%	227.85%	206.1%
Common Stock	$6.000K	$6.000K	$6.000K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$477.1M	$346.3M	$334.4M
YoY Change
Total Liabilities & Shareholders Equity	$510.0M	$369.2M	$356.1M
YoY Change	38.16%	32.25%	34.65%

Cashflow Statement

Concept	2019 Q1	2018 Q1	2017 Q4
OPERATING ACTIVITIES
Net Income	$13.12M	$5.905M	$10.48M
YoY Change	122.17%	45.37%	74.47%
Depreciation, Depletion And Amortization	$4.700M	$4.900M	$700.0K
YoY Change	-4.08%	32.43%	33.84%
Cash From Operating Activities	$32.60M	$19.80M	$22.10M
YoY Change	64.65%	35.62%	42.58%
INVESTING ACTIVITIES
Capital Expenditures	-$3.000M	-$6.800M	-$9.800M
YoY Change	-55.88%	112.5%	127.91%
Acquisitions
YoY Change
Other Investing Activities	$41.30M	-$200.0K	-$3.000M
YoY Change	-20750.0%	100.0%	2900.0%
Cash From Investing Activities	$38.30M	-$6.900M	-$12.70M
YoY Change	-655.07%	109.09%	188.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.600M	2.300M	5.200M
YoY Change	-30.43%	-30.3%	1.96%
NET CHANGE
Cash From Operating Activities	32.60M	19.80M	22.10M
Cash From Investing Activities	38.30M	-6.900M	-12.70M
Cash From Financing Activities	1.600M	2.300M	5.200M
Net Change In Cash	72.50M	15.20M	14.60M
YoY Change	376.97%	4.11%	-9.88%
FREE CASH FLOW
Cash From Operating Activities	$32.60M	$19.80M	$22.10M
Capital Expenditures	-$3.000M	-$6.800M	-$9.800M
Free Cash Flow	$35.60M	$26.60M	$31.90M
YoY Change	33.83%	49.44%	61.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-01-31
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001428336
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	62471952	shares
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q3	dei	Entity Public Float EntityPublicFloat	4100000000	USD
CY2019	dei	Entity Registrant Name EntityRegistrantName	HEALTHEQUITY INC
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2018Q1	hqy	Account Fees Receivable AccountFeesReceivable	7900000	USD
CY2019Q1	hqy	Account Fees Receivable AccountFeesReceivable	6300000	USD
CY2017	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	4297000	USD
CY2018	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	4863000	USD
CY2019	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	5929000	USD
CY2018Q1	hqy	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	240269000	USD
CY2019Q1	hqy	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	361475000	USD
CY2019	hqy	Contract Termination Fee Percentage ContractTerminationFeePercentage	0.75
CY2019	hqy	Contract Termination Written Notice Required ContractTerminationWrittenNoticeRequired	P180D
CY2016Q1	hqy	Cost Method Investment Ownership Percentage CostMethodInvestmentOwnershipPercentage	0.01
CY2019Q1	hqy	Cost Method Investment Ownership Percentage CostMethodInvestmentOwnershipPercentage	0.01
CY2018Q1	hqy	Deferred Tax Assets Operating Loss Carryforwards Noncurrent DeferredTaxAssetsOperatingLossCarryforwardsNoncurrent	666000	USD
CY2019Q1	hqy	Deferred Tax Assets Operating Loss Carryforwards Noncurrent DeferredTaxAssetsOperatingLossCarryforwardsNoncurrent	68000	USD
CY2018Q1	hqy	Deferred Tax Assets Other Noncurrent DeferredTaxAssetsOtherNoncurrent	286000	USD
CY2019Q1	hqy	Deferred Tax Assets Other Noncurrent DeferredTaxAssetsOtherNoncurrent	255000	USD
CY2018Q1	hqy	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax Noncurrent DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTaxNoncurrent	857000	USD
CY2019Q1	hqy	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax Noncurrent DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTaxNoncurrent	0	USD
CY2018Q1	hqy	Deferred Tax Assets Tax Credit Carryforwards Research Noncurrent DeferredTaxAssetsTaxCreditCarryforwardsResearchNoncurrent	2882000	USD
CY2019Q1	hqy	Deferred Tax Assets Tax Credit Carryforwards Research Noncurrent DeferredTaxAssetsTaxCreditCarryforwardsResearchNoncurrent	2323000	USD
CY2018Q1	hqy	Deferred Tax Assets Tax Deferred Expense Compensationand Benefits Employee Bonuses Noncurrent DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeBonusesNoncurrent	489000	USD
CY2019Q1	hqy	Deferred Tax Assets Tax Deferred Expense Compensationand Benefits Employee Bonuses Noncurrent DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsEmployeeBonusesNoncurrent	808000	USD
CY2018Q1	hqy	Deferred Tax Liabilities Incremental Contract Costs DeferredTaxLiabilitiesIncrementalContractCosts	0	USD
CY2019Q1	hqy	Deferred Tax Liabilities Incremental Contract Costs DeferredTaxLiabilitiesIncrementalContractCosts	4654000	USD
CY2017	hqy	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Changein Deferred Tax Rate EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017ChangeinDeferredTaxRate	0	USD
CY2018	hqy	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Changein Deferred Tax Rate EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017ChangeinDeferredTaxRate	458000	USD
CY2018	hqy	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Changein Deferred Tax Rate EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017ChangeinDeferredTaxRate	500000	USD
CY2019	hqy	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Changein Deferred Tax Rate EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017ChangeinDeferredTaxRate	0	USD
CY2018Q1	hqy	Fees Receivablefrom Custodial Banks FeesReceivablefromCustodialBanks	9000000	USD
CY2019Q1	hqy	Fees Receivablefrom Custodial Banks FeesReceivablefromCustodialBanks	13800000	USD
CY2019Q1	hqy	Lessee Leasing Arrangements Operating Leases Annual Increasein Rent Percentage LesseeLeasingArrangementsOperatingLeasesAnnualIncreaseinRentPercentage	0.025
CY2019	hqy	Lessee Leasing Arrangements Operating Leases Number Of Buildings Under Lease LesseeLeasingArrangementsOperatingLeasesNumberOfBuildingsUnderLease	2	building
CY2019	hqy	Self Insurance Maximum Coverage Per Incident SelfInsuranceMaximumCoveragePerIncident	110000	USD
CY2019	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised	0.10
CY2019	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited	14.00
CY2019	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitGranted	50.41
CY2018Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2019Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2019	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised	44.53
CY2019	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited	44.53
CY2019	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitGranted	82.39
CY2018Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	51.44
CY2019Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	82.39
CY2019Q1	hqy	Sharebased Compensation Arrangementby Sharebased Payment Award Additional Shares Availablefor Grants Percentageof Capital Stock Outstanding Percentage SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage	0.03
CY2019	hqy	Sharebased Compensation Arrangementby Sharebased Payment Award Expiration Periodfrom Terminationof Employment SharebasedCompensationArrangementbySharebasedPaymentAwardExpirationPeriodfromTerminationofEmployment	P90D
CY2018Q1	hqy	Unrecognized Tax Benefit Net UnrecognizedTaxBenefitNet	0	USD
CY2019Q1	hqy	Unrecognized Tax Benefit Net UnrecognizedTaxBenefitNet	0	USD
CY2019Q1	hqy	Unrecognized Tax Benefits Amount Netted Against Deferred Tax Assets UnrecognizedTaxBenefitsAmountNettedAgainstDeferredTaxAssets	1693000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2420000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3520000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21602000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25668000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25700000	USD
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5521000	USD
CY2018Q1	hqy	Unrecognized Tax Benefits Amount Netted Against Deferred Tax Assets UnrecognizedTaxBenefitsAmountNettedAgainstDeferredTaxAssets	889000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8552000	USD
CY2018Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7415000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9078000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-269000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	261237000	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	305223000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8398000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14310000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21057000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	16634000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8398000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14310000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21057000	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	208000	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	125000	USD
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	96000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	464000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	933000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11200000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13200000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14700000	USD
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1400000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2018Q1	us-gaap	Assets Assets	369159000	USD
CY2019Q1	us-gaap	Assets Assets	510016000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	265396000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	394677000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	270000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	626000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2018Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40797000	USD
CY2019Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	0	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	25000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	37000	USD
CY2017	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	7700000	USD
CY2018	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	8100000	USD
CY2019	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	9300000	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	19100000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	83641000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	139954000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	199472000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	361500000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	361475000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	199472000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	361475000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	56313000	USD
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	59518000	USD
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	162003000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	240625000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	361475000	USD
CY2019Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	1000000	USD
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60825000	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62446000	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60825000	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62446000	shares
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26309000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	47303000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	73899000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000	USD
CY2019Q1	us-gaap	Cost Method Investments CostMethodInvestments	500000	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	72015000	USD
CY2017Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21680000	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21077000	USD
CY2017Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23062000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28790000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	94609000	USD
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	25548000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	24492000	USD
CY2018Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	24678000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	31332000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	106050000	USD
CY2018Q1	us-gaap	Credit Card Receivables CreditCardReceivables	4700000	USD
CY2019Q1	us-gaap	Credit Card Receivables CreditCardReceivables	5600000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	14848000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	392000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1095000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16671000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	522000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1511000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1823000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	130000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	416000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2308000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4068000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1258000	USD
CY2018Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5461000	USD
CY2019Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1677000	USD
CY2018Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1274000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2927000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4305000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	408000	USD
CY2018Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6127000	USD
CY2019Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10873000	USD
CY2018Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2019Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	916000	USD
CY2018Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18000	USD
CY2017	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-2891000	USD
CY2018	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	4306000	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	408000	USD
CY2018Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2395000	USD
CY2019Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2968000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-619000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	237000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-850000	USD
CY2018Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11588000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11731000	USD
CY2018Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	5461000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	761000	USD
CY2018Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11588000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11634000	USD
CY2018Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5316000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6987000	USD
CY2018Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	572000	USD
CY2019	us-gaap	Depreciation Depreciation	3500000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13186000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	664000	USD
CY2018Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	520000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	626000	USD
CY2018Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2019Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	97000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	100000	USD
CY2017	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	16634000	USD
CY2018	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	0	USD
CY2019	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	0	USD
CY2018Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4830000	USD
CY2019Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4798000	USD
CY2018Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	127000	USD
CY2019Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	127000	USD
CY2018Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1170000	USD
CY2019Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1294000	USD
CY2017	us-gaap	Depreciation Depreciation	2000000	USD
CY2018	us-gaap	Depreciation Depreciation	2800000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15952000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18185000	USD
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.20
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.17
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.343
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.092
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.025
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4734000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4306000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	127653000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	132827000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	83635000	USD
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	0	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-14136000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-14255000	USD
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12549000	USD
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16981000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M0D
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	11600000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	44018000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	53161000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	34788000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	13824000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6209000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6209000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7930000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	10706000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	79666000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-700000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20151000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25111000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33039000	USD
CY2018Q1	us-gaap	Goodwill Goodwill	4651000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	4651000	USD
CY2017	us-gaap	Gross Profit GrossProfit	106355000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	33741000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	35802000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	33727000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	31646000	USD
CY2018	us-gaap	Gross Profit GrossProfit	134916000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	44356000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	46575000	USD
CY2018Q4	us-gaap	Gross Profit GrossProfit	45817000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	44445000	USD
CY2019	us-gaap	Gross Profit GrossProfit	181193000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	40120000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	52189000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	75818000	USD
CY2018Q1	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	USD
CY2019Q1	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13744000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1808000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-489000	USD
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-65000	USD
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	223000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2685000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	823000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4827000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2038000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1029000	USD
CY2018Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1745000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3241000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1919000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-300000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-308000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	13641000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	17744000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	15922000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	87000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	143000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	411000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	125000	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	742000	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1241000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1518000	USD
CY2017	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	246000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	191000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	450000	USD
CY2017	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	907000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	729000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2252000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	863000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	27000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	587000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	567000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-581000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	863000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2728000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1729000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	484000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3031000	USD
CY2017	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	946000	USD
CY2018	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	3827000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4432000	USD
CY2017	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	1220000	USD
CY2018	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	939000	USD
CY2019	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	573000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1343000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	760000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5893000	USD
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1279000	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1550000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1534000	shares
CY2018Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	83635000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	79666000	USD
CY2017	us-gaap	Interest Paid InterestPaid	213000	USD
CY2018	us-gaap	Interest Paid InterestPaid	203000	USD
CY2019	us-gaap	Interest Paid InterestPaid	203000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	22885000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	32937000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	369159000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	510016000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	20490000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	29053000	USD
CY2018Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2395000	USD
CY2019Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3884000	USD
CY2018	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	900000	USD
CY2019	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	400000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23776000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14564000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22929000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13054000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36748000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25652000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45591000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	81702000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	113422000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	26376000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	14029000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	16946000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	10482000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	5905000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	47362000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1706000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	22577000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	22517000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	15686000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	13119000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	73899000	USD
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2017	us-gaap	Operating Expenses OperatingExpenses	65143000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	17814000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	19307000	USD
CY2017Q4	us-gaap	Operating Expenses OperatingExpenses	20165000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	23212000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	80498000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	23816000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	25012000	USD
CY2018Q4	us-gaap	Operating Expenses OperatingExpenses	26831000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	27864000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	103523000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	41212000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	54418000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	77670000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	77844000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	7258000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5883000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5798000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	7328000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7325000	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	44252000	USD
CY2018Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3525000	USD
CY2019Q1	us-gaap	Other Assets Current OtherAssetsCurrent	7534000	USD
CY2018Q1	us-gaap	Other Assets Current OtherAssetsCurrent	4676000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2180000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21122000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18027000	USD
CY2017	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-67000	USD
CY2018	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-59000	USD
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-67000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-59000	USD
CY2017	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1092000	USD
CY2018	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	2229000	USD
CY2019	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1852000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1092000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-90000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-38000	USD
CY2017Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-395000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2229000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-75000	USD
CY2018Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1555000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-221000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1852000	USD
CY2017	us-gaap	Payments For Software PaymentsForSoftware	9030000	USD
CY2018	us-gaap	Payments For Software PaymentsForSoftware	10380000	USD
CY2019	us-gaap	Payments For Software PaymentsForSoftware	9978000	USD
CY2017	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2018	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2882000	USD
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	17545000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1195000	USD
CY2017	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	379000	USD
CY2018	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	483000	USD
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	728000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3645000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5458000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3869000	USD
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2018	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	41422000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7142000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14564000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	22929000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15251000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17301000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7836000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8223000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	35000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	133000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	240000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22375000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27385000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35057000	USD
CY2017	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	10000000	USD
CY2018	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	12200000	USD
CY2019	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	13700000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	85300000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	171850000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	98307000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71067000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	70495000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75777000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	287243000	USD
CY2018Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	400000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	300000	USD
CY2017	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18320000	USD
CY2018	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23139000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29498000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	8398000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	14310000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	21057000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	178370000	USD
CY2017Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55421000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56879000	USD
CY2017Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56789000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	60436000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	229525000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	69904000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2600000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4100000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1100000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	800000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	23.19
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	50094000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	44823000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	65463000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	30.50
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	119000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1399000	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	420000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	140000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	28.85
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	42.72
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	64.06
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	102796000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	85971000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3699000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2444000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.83
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	27.37
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	85971000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	843000	shares
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	477079000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	674000	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61836000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2444000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	27.37
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	17.97
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	64.06
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	33023000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M11D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M5D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M28D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y8M28D
CY2018Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	800000	USD
CY2019Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	1500000	USD
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1276000	shares
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7142000	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14564000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22929000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	203457000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	261940000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	346274000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	889000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	900000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1693000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1700000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	215000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	805000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	800000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59894000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61854000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63370000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58615000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60304000	shares
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Concentration of credit risk</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash. The Company maintains its cash and cash equivalents in bank and other depository accounts, which, frequently exceeds federally insured limits.</font></div></div>
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Use of estimates</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management has made estimates for the allowance for doubtful accounts, capitalized software development costs, evaluating goodwill and long-lived assets for impairment, useful lives of property and equipment and intangible assets, accrued compensation, accrued liabilities, grant date fair value of stock options and income taxes. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001428336-19-000006-index-headers.html	Edgar Link	pending
0001428336-19-000006-index.html	Edgar Link	pending
0001428336-19-000006.txt	Edgar Link	pending
0001428336-19-000006-xbrl.zip	Edgar Link	pending
exhibit1028billottenofferlet.htm	Edgar Link	pending
exhibit1029ashleydreieroff.htm	Edgar Link	pending
exhibit1030restrictedstock.htm	Edgar Link	pending
exhibit1031thirdamendmentt.htm	Edgar Link	pending
exhibit1032amendedandresta.htm	Edgar Link	pending
exhibit2312019-1x31.htm	Edgar Link	pending
exhibit3112019-1x31ceo.htm	Edgar Link	pending
exhibit3122019-1x31cfo.htm	Edgar Link	pending
exhibit3212019-1x31ceo.htm	Edgar Link	pending
exhibit3222019-1x31cfo.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
healthequitylogosecondarya01.jpg	Edgar Link	pending
healthequitylogosecondarya02.jpg	Edgar Link	pending
hqy-2015x01x3_chartx02552a03.jpg	Edgar Link	pending
hqy-20190131.xml	Edgar Link	completed
hqy-20190131.xsd	Edgar Link	pending
hqy-20190131_cal.xml	Edgar Link	unprocessable
hqy-20190131_def.xml	Edgar Link	unprocessable
hqy-20190131_lab.xml	Edgar Link	unprocessable
hqy-20190131_pre.xml	Edgar Link	unprocessable
hqy-2019x01x3110k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HQY
HEALTHEQUITY, INC. Stock $hqy

2019 Q1 Form 10-K Financial Statement

#000142833619000006 Filed on March 28, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY HEALTHEQUITY, INC. Stock $hqy

2019 Q1 Form 10-K Financial Statement

#000142833619000006 Filed on March 28, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY
HEALTHEQUITY, INC. Stock $hqy